Curcumin Inhibits the Activation of Immunoglobulin E-Mediated Mast Cells and Passive Systemic Anaphylaxis in Mice by Reducing Serum Eicosanoid and Histamine Levels
Biomolecules & Therapeutics
;
: 27-34, 2014.
Article
in English
| WPRIM
| ID: wpr-138517
ABSTRACT
Curcumin is naturally occurring polyphenolic compound found in turmeric and has many pharmacological activities. The present study was undertaken to evaluate anti-allergic inflammatory activity of curcumin, and to investigate its inhibitory mechanisms in immunoglobulin E (IgE)/Ag-induced mouse bone marrow-derived mast cells (BMMCs) and in a mouse model of IgE/Ag-mediated passive systemic anaphylaxis (PSA). Curcumin inhibited cyclooxygenase-2 (COX-2) dependent prostaglandin D2 (PGD2) and 5-lipoxygenase (5-LO) dependent leukotriene C4 (LTC4) generation dose-dependently in BMMCs. To probe the mechanism involved, we assessed the effects of curcumin on the phosphorylation of Syk and its downstream signal molecules. Curcumin inhibited intracellular Ca2+ influx via phospholipase Cgamma1 (PLCgamma1) activation and the phosphorylation of mitogen-activated protein kinases (MAPKs) and the nuclear factor-kappaB (NF-kappaB) pathway. Furthermore, the oral administration of curcumin significantly attenuated IgE/Ag-induced PSA, as determined by serum LTC4, PGD2, and histamine levels. Taken together, this study shows that curcumin offers a basis for drug development for the treatment of allergic inflammatory diseases.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phospholipases
/
Phosphorylation
/
Arachidonate 5-Lipoxygenase
/
Immunoglobulin E
/
Immunoglobulins
/
Prostaglandin D2
/
Histamine
/
Administration, Oral
/
Leukotriene C4
/
Mitogen-Activated Protein Kinases
Type of study:
Prognostic study
Limits:
Animals
Language:
English
Journal:
Biomolecules & Therapeutics
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS